The Royal College of Psychiatrists, Heroic Hearts and other leading mental health charities have written letters to the Veterans Minister and the Minister of State for...
Psychedelics work by altering neural networks in our brains – this first-of-its-kind partnership between Clerkenwell Health and MYndspan will help understand this link definitively, and provide...
Two new drug candidates have been developed for the treatment of addiction and depression that have been modelled on the pharmacology of a traditional African psychoactive...
The use of psychedelics in research has a long and storied history, dating back to the mid-20th century.
With psilocybin showing promise for treating conditions such as depression and addiction, a team of scientists from the University of Southern Denmark has set out to...
As the mental health crisis continues to escalate, those suffering from mental health issues are seeking new solutions to combat PTSD, depression, anxiety, trauma and other...
A new study has investigated whether psilocybin could be the key to restore ‘fear extinction’ and thus help treat post-traumatic stress disorder (PTSD).
A team of researchers have found that patterns of activity in the brain associated with nitrous oxide, ketamine and LSD overlap, suggesting a common underlying biology.
Psychedelics and creativity have been linked in anecdotal evidence from artists, scientists, actors, entertainers and musicians.
Cybin has announced the completion of dosing the last subject in Part B of its three-part CYB004-E Phase 1 trial evaluating intravenous (IV) DMT in healthy...
The first patient in Beckley Psytech’s trial investigating its patent-protected benzoate formulation of 5-MeO-DMT – BPL-003 – as a therapy for Treatment Resistant Depression (TRD) has...
An increasing amount of research is showing psychedelics as promising treatments for a variety of mental health conditions, however, a group of experts have emphasised the...